Skip to main content
. 2021 Jul 25;12:20420986211027451. doi: 10.1177/20420986211027451

Figure 2.

Figure 2.

An overview of cardiovascular medication harm across four healthcare settings.

aRate reported for all adults, as limited literature exists for older persons.

bIncludes intravenous and oral antiarrhythmics.

ACE-I, angiotensin-converting enzyme inhibitors; BB, beta-blockers; CCBs, calcium-channel blockers; CV, cardiovascular.